Australian Doctor 
 News

TikTok blamed for the semaglutide shortage

A sudden rush on off-label scripts for the diabetes drug coincides with spruiking by ‘influencers’
2
1 June 2022
Save
Diabetes pen

GPs are being urged not to prescribe semaglutide (Ozempic) off label for obesity management as surging demand has created a shortage of the drug for people with type 2 diabetes. 

Semaglutide manufacturer Novo Nordisk has informed the TGA that both strengths of the Ozempic pre-filled pen are in short supply as a result of an unexpected increase in patient demand.

Report

Harassment or bullying behavior
Contains mature or sensitive content
Contains misleading or false information
Contains abusive or derogatory content
Content that breaches the privacy of other individuals
Contains spam, fake content or potential malware

Block Member?

Please confirm you want to block this member.

You will no longer be able to:

  • See blocked member's posts
  • Mention this member in posts
  • Message this member
  • Add this member as a connection

Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.

Report

You have already reported this .